Get trade alerts

Pharvaris N.V ($PHVS) Insider Trading & Smart Money Activity

Pharvaris N.V. · Biotechnology · Latest filing Sep 23, 2026

Pharvaris N.V. ($PHVS) has 14 insider trades and 2 analyst ratings on file. In the last 12 months on the open market, no insider bought and 8 insiders sold ($15.04M), net -$15.04M.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
8
Net insider $ (12 mo)
-$15.04M
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
2

PHVS insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 2 · $584.04K 0 / 0 0 / 0
Q3 2026 0 8 · $14.46M 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All PHVS insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Monges VivianeDirector Sell (Open-market sale) 11.97K sh $395.52K -4.1% —
Insider Schikan Johannes Gerardus Christiaan PetrusDirector Sell (Open-market sale) 800 sh $28.95K -9.9% —
Insider Nassif David W.CFO / CLO Sell (Open-market sale) 6K sh $218.80K -11.4% —
Insider Schikan Johannes Gerardus Christiaan PetrusDirector Sell (Open-market sale) 200K sh $7M -13.2% —
Insider Lu PengPresident Sell (Open-market sale) 100K sh $3.50M -13.2% —
Insider Lesage AnneChief Early Development Sell (Open-market sale) 20K sh $765.47K -13.2% —
Insider Glassman RobertDirector Sell (Open-market sale) 10b5-1 14.49K sh $558.81K -13.2% —
Insider Bjork ElisabethDirector Sell (Open-market sale) 52.50K sh $1.99M -13.2% —
Insider Schikan Johannes Gerardus Christiaan Petrus Sell (Open-market sale) 10b5-1 2.40K sh $84.24K -4.3%-6.0% —
Insider Peng LuChief Medical Officer Sell (Open-market sale) 10b5-1 14.70K sh $499.80K -2.3%-0.1% —
Insider Peng LuChief Medical Officer Buy (Option exercise) 14.70K sh $38.07K -2.3%-0.1% —
Analyst Morgan Stanley Reiterates to buy PT $46 +1.7%+2.0% Read
Analyst Morgan Stanley Reiterates to buy PT $46 +1.7%+2.0% Read
Insider Peng LuChief Medical Officer Sell (Option exercise) 15K sh +1.7%+2.0% —
Insider Anne LesageChief Early Development Buy (Option exercise) 2.30K sh $10.87K +1.7%+2.0% Read
Insider Peng LuChief Medical Officer Sell (Option exercise) 300 sh +1.5%+2.3% Read

1W / 1M / 6M = how PHVS moved from the trade or filing date.

Insider trading in PHVS: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Monges Viviane Director 1 -$395.52K Sep 23, 2026
Schikan Johannes Gerardus Christiaan Petrus Director 3 -$7.11M Sep 22, 2026
Nassif David W. CFO / CLO 1 -$218.80K Sep 21, 2026
Lu Peng President 1 -$3.50M Sep 17, 2026
Lesage Anne Chief Early Development 1 -$765.47K Sep 17, 2026
Glassman Robert Director 1 -$558.81K Sep 17, 2026
Bjork Elisabeth Director 1 -$1.99M Sep 17, 2026
Peng Lu Chief Medical Officer 4 -$499.80K Jun 26, 2026
Anne Lesage Chief Early Development 1 — Jun 25, 2026

Analyst ratings on PHVS

DateFirmActionRatingPrice target1W1M6MStory
Morgan Stanley Reiterates buy $46 +1.7%+2.0% Read
Morgan Stanley Reiterates buy $46 +1.7%+2.0% Read

Frequently asked questions

Are PHVS insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 8 insiders made 10 open-market sales worth $15.04M, a net -$15.04M.

What is the latest insider trade in PHVS?

Monges Viviane, Director filed a sell (open-market sale) of 11.97K sh worth $395.52K on Sep 23, 2026.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text